✦ LIBER ✦

Anti-tumor activity of the HSP90 inhibitor SNX-2112 in pediatric cancer cell lines

✍ Scribed by Danielle C. Chinn; William S. Holland; Janet M. Yoon; Theodore Zwerdling; Philip C. Mack

Book ID: 112167908
Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 408 KB
Volume: 58
Category: Article
ISSN: 1545-5009
DOI: 10.1002/pbc.23270

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Hsp90 inhibitors deplete key anti-apopto

Hsp90 inhibitors deplete key anti-apoptotic proteins in pediatric solid tumor cells and demonstrate synergistic anticancer activity with cisplatin

✍ Rochelle Bagatell; Jason Beliakoff; Cynthia L. David; Marilyn T. Marron; Luke Wh 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 626 KB

## Abstract Drugs that inhibit the function of heat shock protein 90 (Hsp90) are of interest in the treatment of pediatric cancers because these agents deplete the cellular levels of signaling molecules that are important for the growth and survival of many childhood tumors. To generate preclinical

A novel class of specific Hsp90 small mo

A novel class of specific Hsp90 small molecule inhibitors demonstrate in vitro and in vivo anti-tumor activity in human melanoma cells

✍ Pramod P. Mehta; Pei-Pei Kung; Shinji Yamazaki; Marlena Walls; Andrea Shen; Lesl 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 670 KB

Resveratrol enhances the anti-tumor acti

Resveratrol enhances the anti-tumor activity of the mTOR inhibitor rapamycin in multiple breast cancer cell lines mainly by suppressing rapamycin-induced AKT signaling

✍ Xin He; Yu Wang; Jinhong Zhu; Mohammed Orloff; Charis Eng 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 854 KB

The novel Hsp-90 inhibitor SNX7081 is si

The novel Hsp-90 inhibitor SNX7081 is significantly more potent than 17-AAG against primary CLL cells and a range of haematological cell lines, irrespective of lesions in the TP53 pathway

✍ O. Giles Best; Nisha Singh; Cecily Forsyth; Stephen P. Mulligan 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 155 KB

Hsp90 inhibitors cause G2/M arrest assoc

Hsp90 inhibitors cause G2/M arrest associated with the reduction of Cdc25C and Cdc2 in lung cancer cell lines

✍ Megumi Senju; Naoko Sueoka; Akemi Sato; Kentaro Iwanaga; Yukinori Sakao; Shinji 📂 Article 📅 2005 🏛 Springer-Verlag 🌐 English ⚖ 494 KB

cGMP-independent anti-tumour actions of

cGMP-independent anti-tumour actions of the inhibitor of soluble guanylyl cyclase, ODQ, in prostate cancer cell lines

✍ G Haramis; Z Zhou; A Pyriochou; M Koutsilieris; C Roussos; A Papapetropoulos 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 240 KB